Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administration.

[1]  D. Goldstein,et al.  Neuronal source of plasma dihydroxyphenylalanine. , 1987, The Journal of clinical endocrinology and metabolism.

[2]  D. Edwards,et al.  Effects of debrisoquin on the excretion of catecholamine and octopamine metabolites in the rat and guinea pig. , 1985, Biochemical pharmacology.

[3]  C. Bowden,et al.  Effects of debrisoquin on CSF and plasma HVA concentrations in man. , 1985, Life sciences.

[4]  H. Pakkenberg,et al.  The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). , 1985, The New England journal of medicine.

[5]  I. Kopin,et al.  Urinary catecholamine metabolites distinguish different types of sympathetic neuronal dysfunction in patients with orthostatic hypotension. , 1983, The Journal of clinical endocrinology and metabolism.

[6]  R. Roth,et al.  Plasma homovanillic acid as an index of brain dopamine metabolism: enhancement with debrisoquin. , 1983, Life sciences.

[7]  S. Markey,et al.  Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry. , 1981, Biomedical mass spectrometry.

[8]  H. Landis,et al.  Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin. , 1980, Life sciences.

[9]  J. Maas,et al.  A DIRECT METHOD FOR DETERMINING DOPAMINE SYNTHESIS AND OUTPUT OF DOPAMINE METABOLITES FROM BRAIN IN AWAKE ANIMALS , 1979, Journal of neurochemistry.

[10]  R. Wurtman,et al.  EFFECT OF SELECTIVE DESTRUCTION OF CENTRAL AND PERIPHERAL CATECHOLAMINE‐CONTAINING NEURONES WITH 6‐HYDROXYDOPAMINE ON CATECHOLAMINE EXCRETION IN THE RAT , 1974, British journal of pharmacology.

[11]  O. Hornykiewicz.  Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). , 1973, British medical bulletin.

[12]  R. Banziger,et al.  CARDIOVASCULAR EFFECTS OF 3,4-DIHYDRO-2(1H) ISOQUINOLINE CARBOXAMIDINE (DECLINAX-T.M.). , 1964, Current therapeutic research, clinical and experimental.

[13]  Lorenzo Finesso.  STATISTICAL METHODS , 1937 .